Page 31 - ARNM-3-2

Advances in Radiotherapy
& Nuclear Medicine Lipid-radiotherapy crosstalk in cancer

studies. Int J Environ Res Public Health. 2022;19(14):8272. 33. Jin Y, Chen Z, Dong J, et al. SREBP1/FASN/cholesterol axis
facilitates radioresistance in colorectal cancer. FEBS Open
doi: 10.3390/ijerph19148272
Bio. 2021;11(5):1343-1352.
27. Goldberg JF, Hyun G, Ness KK, et al. Dyslipidemia and
cardiovascular disease among childhood cancer survivors: doi: 10.1002/2211-5463.13137
A St. Jude lifetime cohort report. J Natl Cancer Inst. 34. Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis,
2024;116(3):408-420. radiotherapy, and combination therapeutic strategies.
Protein Cell. 2021;12(11):836-857.
doi: 10.1093/jnci/djad222
doi: 10.1007/s13238-021-00841-y
28. Cheng YW, Chen CH, Yeh SJ, et al. Association between
modifiable vascular risk factors and rapid progression of 35. Tao X, Zhou Q, Rao Z. Efficacy of ω-3 polyunsaturated fatty
postradiation carotid artery stenosis. J Chin Med Assoc. acids in patients with lung cancer undergoing radiotherapy
2023;86(7):627-632. and chemotherapy: A meta-analysis. Int J Clin Pract.
2022;2022:6564466.
doi: 10.1097/JCMA.0000000000000936
doi: 10.1155/2022/6564466
29. Wang X, Palaskas NL, Hobbs BP, et al. The impact of
radiation dose to heart substructures on major coronary 36. Polański J, Świątoniowska-Lonc N, Kołaczyńska S,
events and patient survival after chemoradiation therapy for Chabowski M. Diet as a factor supporting lung cancer
esophageal cancer. Cancers (Basel). 2022;14(5):1304. treatment-a systematic review. Nutrients. 2023;15(6):1477.
doi: 10.3390/cancers14051304 doi: 10.3390/nu15061477
30. He Y, Qi S, Chen L, et al. The roles and mechanisms of 37. Lin CY, Chang CL, Lin KC, et al. Statin use reduces radiation-
SREBP1 in cancer development and drug response. Genes induced stroke risk in advanced nasopharyngeal carcinoma
Dis. 2024;11(4):100987. patients. Radiother Oncol. 2024;191:110067.
doi: 10.1016/j.gendis.2023.04.022 doi: 10.1016/j.radonc.2023.110067
31. Mousavikia SN, Darvish L, Firouzjaei AA, Toossi MTB, 38. Addison D, Lawler PR, Emami H, et al. Incidental statin
Azimian H. PI3K/AKT/mTOR targeting in colorectal use and the risk of stroke or transient ischemic attack
cancer radiotherapy: A systematic review. J Gastrointest after radiotherapy for head and neck cancer. J Stroke.
Cancer. 2025;56(1):52. 2018;20(1):71-79.
doi: 10.1007/s12029-024-01160-1 doi: 10.5853/jos.2017.01802
32. Li P, Cui Y, Hu K, Wang X, Yu Y. Silencing APLNR enhances 39. Boulet J, Peña J, Hulten EA, et al. Statin use and risk of
the radiosensitivity of prostate cancer by modulating the vascular events among cancer patients after radiotherapy
PI3K/AKT/mTOR signaling pathway. Clin Transl Oncol. to the thorax, head, and neck. J Am Heart Assoc.
2024. 2019;8(13):e005996.
doi: 10.1007/s12094-024-03692-1 doi: 10.1161/JAHA.117.005996

Volume 3 Issue 2 (2025) 23 doi: 10.36922/ARNM025070006